West Nile Virus Symptom Susceptibility / Risk (WNVR)
Gene or Region: OAS1
Reference Variant: C
Mutant Variant: T
Affected Breeds: Many
Research Confidence: Preliminary - Reproduced in studies of other mammals
Explanation of Results: WNVR/WNVR = homozygous for West Nile Virus Resistance/Susceptibility, higher risk WNVR/n = heterozygous for West Nile Virus Resistance/Susceptibility, increased risk n/n = no variant detected
General Information
West Nile virus is a mosquito-borne virus that can infect multiple types of mammals, including horses. Infection can lead to a series of severe symptoms, most commonly encephalitis – acute inflammation of the brain. Severe neurological symptoms develop in ~8% of exposed horses, and once symptoms manifest, the fatality rate ranges from 20-40% and is higher in older horses. Originally found in Africa, it spread to the United States in 1999 and equine cases are currently reported on all continents. Cases of WNV peaked in the USA in 2002, with over fifteen thousands equine cases reported; it has since declined due to the introduction of an equine vaccine.
OAS1 encodes an antiviral protein that activates virus-degrading enzymes within the cell. The particular SNP assessed here occurs in the promoter of OAS1, a DNA sequence that modulates expression of the OAS1 gene.
This testing indicates which genetic variant your horse may have and the resulting "susceptibility" or symptom severity that your horse may experience if he/she contracts West Nile Virus. It does not indicate presence of the disease or any form of titer indicating past infection. If your horse is negative (-/-) then he/she is assumed to be in the lowest-risk category for symptom severity. The presence of one variant (+/-) is detected, then the risk for symptom severity in your horse is moderate. If two variants are detected (+/+) these results correlated with the most severe symptom onset and your horse is possibly in the highest risk category for symptom onset and severity.
How should risk variant information be used? For any disease, disorders or medical questions, you should always consult your veterinarian so they may assess this information along with the current knowledge and health history of your horse. While it is always advisable to inoculate your horse, this information may be helpful in further assessing how often you inoculate based on your horse's disease susceptibility, your situation, and geographical location. Be sure to consult your veterinarian for the best possible practice when it concerns the health of your horse.
References
Angenvoort et al., “West Nile viral infection of equids.” (2013) Veterinary Microbiology 167: 168-170. PMID: 24035480
Rios et al., “OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.” (2010) PLoS One 5: e10537. PMID: 20479874
More Horse Health
"Warmblood" Fragile Foal Syndrome
"Warmblood" fragile foal syndrome (FFS) is a connective tissue disorder resulting in joint laxity and extremely thin skin that is only loosely connected to the body. The skin is easily torn, resulting in lacerations, hematomas, and seromas across the foal. Affected foals are euthanized shortly after birth.
Androgen Insensitivity Syndrome
Androgen Insensitivity Syndrome (AIS) is an X-linked disorder of sexual development resulting in a female horse with XY chromosomes. Horses with AIS exhibit stallion-like behavior such as agression toward other horses, Flehman response and vocalization toward cycling mares.
Cerebellar Abiotrophy
Cerebellar Abiotrophy (CA) is a degenerative neurological disorder, due to the death of neurons in the brain. Symptoms (head tremors, lack of coordination, wide stances, exaggerated gain, difficulty rising and startling easily), typically appear in foals between six weeks and four months of age.